Efficacy and Safety of HB-1 for Panic Disorder

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(22 sites)

Australia

Paratus Clinical Research Canberra, Canberra, Australian Capital Territory

Paratus Clinical Research Western Sydney, Blacktown, New South Wales

East Sydney Doctors, Darlinghurst, New South Wales

Momentum Clinical Research Darlinghurst, Darlinghurst, New South Wales

Paratus Clinical Research Central Coast, Kanwal, New South Wales

Novatrials, Kotara, New South Wales

Canopy Clinical Sutherland, Miranda, New South Wales

Innovate Clinical Research, Waitara, New South Wales

Westmead Hospital, Westmead, New South Wales

Canopy Clinical Wollongong, Wollongong, New South Wales

Paratus Clinical Research Brisbane, Herston, Queensland

Mackay Hospital and Health Service, Mackay, Queensland

Gold Coast University Hospital, Southport, Queensland

South Australian Health and Medical Research Institute, Adelaide, South Australia

Lyell McEwin Hospital, Elizabeth Vale, South Australia

Grampians Health, Ballarat, Victoria

NeuroCentrix, Carlton, Victoria

Peninsula Therapeutic and Research Group, Frankston, Victoria

Multidisciplinary Alfred Psychiatry Research Clinic, Melbourne, Victoria

Ramsay Clinic Albert Road, Melbourne, Victoria

Paratus Clinical Research Melbourne, Northcote, Victoria

Clinitrials, Perth, Western Australia